Our data suggest that the effect of RAPA on obesity and improved systemic insulin sensitivity may be mediated partly through downregulation of MEST‐facilitated fat mass expansion and the related tissue hypoxia and adipose tissue inflammation. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.